APHD VERDE BIO HOLDINGS, INC.
Crude Petroleum & Natural Gas · OTC · SEC CIK 1490054 · Fiscal year ends 04/30
Financial factors as of 2024-01-31 (2024Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-45.3%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE-190.1%
ROA-85.1%
ROIC (approx.)-83.9%
Asset turnover—
Leverage & solvency
Liabilities / assets84.8%
Debt / equity0.00x
Current ratio—
Interest coverage-38.29x
Cash quality & payout
Operating cash flow / net income0.42x
Accruals ratio-49.7%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2024Q32024-01-31 | 2024Q22023-10-31 | 2024Q12023-07-31 | 2023Q4*2023-04-30 | 2023Q32023-01-31 | 2023Q22022-10-31 | 2023Q12022-07-31 | 2022Q4*2022-04-30 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | — | — | — | — | — | — | — | — |
| SG&A expense | $206,944 | — | — | — | $235,535 | — | — | — |
| Operating income | -$410,490 | -$303,328 | -$326,953 | -$402,013 | -$414,177 | -$125,275 | -$698,461 | -$420,515 |
| Interest expense | $0 | $10,834 | $728 | $26,116 | $9,699 | $2,716 | $27,347 | $0 |
| Pretax income | -$1.49M | — | — | -$440,344 | -$439,836 | — | — | — |
| Net income | -$1.49M | -$350,826 | -$336,648 | -$460,619 | -$439,836 | -$154,316 | -$786,617 | -$436,918 |
| EBITDA | -$395,008 | -$287,845 | -$224,014 | -$411,703 | -$398,694 | -$109,793 | -$683,327 | -$400,921 |
| EPS (basic) | 0.00 | — | — | — | 0.00 | — | — | — |
| EPS (diluted) | 0.00 | — | — | — | 0.00 | — | — | — |
| Weighted avg. shares (diluted) | 1.86B | — | — | — | 1.37B | — | — | — |
| Balance sheet | ||||||||
| Cash & equivalents | $11,561 | $39,975 | $200,265 | $25,836 | $50,063 | $77,665 | $101,110 | $141,206 |
| Receivables | $53,077 | — | — | $71,912 | — | — | — | — |
| Current assets | $104,378 | $111,164 | $294,751 | $97,748 | $165,309 | $224,554 | $262,342 | $295,873 |
| PP&E, net | $1.08M | $2.69M | $2.71M | $2.72M | $2.74M | $2.76M | $2.77M | $2.78M |
| Total assets | $1.88M | $3.70M | $3.94M | $4.16M | $4.33M | $4.67M | $4.89M | $5.09M |
| Current liabilities | — | — | — | $1.84M | $1.58M | $1.56M | $1.70M | $1.45M |
| Total liabilities | $1.60M | $2.01M | $1.92M | $1.84M | $1.58M | $1.56M | $1.71M | $1.47M |
| Shareholders' equity | $119,018 | $1.54M | $1.89M | $2.21M | $2.66M | $3.05M | $3.14M | $3.59M |
| Shares outstanding | 1.93B | 1.76B | 1.68B | 1.54B | 1.42B | 1.32B | 1.28B | 1.18B |
| Cash flow statement | ||||||||
| Operating cash flow | -$314,334 | -$240,290 | -$388,585 | -$155,208 | -$306,542 | $16,635 | -$427,111 | -$8,848 |
| Capital expenditure | $68,881 | $0 | $0 | $0 | $0 | $0 | $6,985 | $193,076 |
| Free cash flow | -$383,215 | -$240,290 | -$388,585 | -$155,208 | -$306,542 | $16,635 | -$434,096 | -$201,924 |
| Investing cash flow | $150,000 | $0 | $329,869 | $0 | $175,000 | -$20,000 | -$6,985 | -$561,076 |
| Financing cash flow | $135,920 | $80,000 | $233,145 | $130,981 | $103,940 | -$20,080 | $394,000 | -$1 |
| Depreciation & amortization | $15,482 | $15,483 | $102,939 | -$9,690 | $15,483 | $15,482 | $15,134 | $19,594 |
Free plan shows the latest 8 periods; Pro shows all 56 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.